SORL1 and ovarian serous adenocarcinoma: In this study, we identified the upregulation of SORL1 in recurrent ovarian cancer and demonstrated SORL1’s role in promoting carboplatin resistance using a common ovarian cancer cell line, OVCAR8, and a patient-derived high-grade serous ovarian cancer cell line, KRCH31.